GLP-1 Agonists: A Comprehensive Overview
US$ 29.36
glp-1 drugs pharmaceutical companies partnerships 2025 Market Trends and Global Forecasts Report 2025: A glp-1 drugs pharmaceutical companies partnerships
Description
26 Hemorrhage, edema, ischemia, and necrosis can ensue
Saxena AR, Gorman DN, Esquejo RM et al (2021) Danuglipron (PF-06882961) in type 2 diabetes: a randomized placebo-controlled multiple ascending-dose phase 1 trial
Many participants lost an average percentage of their body weight similar to early-stage GLP-1 injection trials, which is why experts believe it may emerge as a major rival to injectable GLP-1 receptor agonists
Unusual delivery methods
Zobel, E
This work is published and licensed by Dove Medical Press Limited
